Objective: To determine if cervical ripening with the prostaglandin E2 analogue dinoprostone effectively shortens the inductionto-delivery interval in midpregnancy terminations with sulprostone. Study design: We retrospectively studied 100 women admitted for pregnancy termination at midgestation because of fetal anomalies between September 1989 and January 1993. Three regimens were used: 27 women received intramuscular sulprostone only, 29 women received intravenous sulprostone only, and 44 women received intravenous sulprostone after cervical priming with dinoprostone. Wilcoxon's rank sum test was used for statistical analy sis. Results: Dinoprostone priming did not significantly reduce the induction-to-delivery interval in either parous or nulliparous women. However, when divided into first and subsequent pregnancies, we found that primigravidae, but not multigravidae, had an induction-to-delivery interval that was significantly shorter by approximately 10.5 h when pretreated with dinoprostone. Conclu sion: Dinoprostone priming of the cervix prior to termination of midgestation pregnancy with sulprostone (Nalador) effectively shortens the induction-to-delivery interval in women in their first pregnancy.
Introduction
T erm ination o f second trim ester pregnancy for fetal anomalies is com m only carried o u t in Europe w ith the use o f the prostaglandin analogue, 16-phenoxy-17,18, 19,20 tetran o r P G E 2 m ethylsulphonam ide (sulprostone, Nalador®). Sulprostone can either be given as con tinuous intravenous infusion or by repeated in tra m uscular injections. Because continuous intravenous in fusion is easier to control, produces less side effects and requires a lower to tal dose, continuous intravenous infu sion has replaced intram uscular injections in recent years [1] , Cervical application o f prostaglandin E2 (dinopro stone, Cerviprost®) has been used b o th for ripening o f the cervix prior to induction o f labour at term [2] prior to first trim ester term ination o f pregnancy [3] . Based on the idea th at intracervical dinoprostone might facilitate term ination o f second trim ester pregnancy with the use o f sulprostone, and some encouraging earlier reports [4] [5] [6] , patients w ho were adm itted for ter m ination o f m idgestation pregnancy with sulprostone were routinely pretreated with dinoprostone at our De partm ent o f Gynaecology from July 1991 onwards.
T o evaluate if prim ing o f the cervix with dinoprostone indeed effectively shortens the time to delivery o f the fetus after the initiation o f sulprostone adm inistration, we retrospectively analysed the data o f women adm itted for term ination o f pregnancy.
M aterials and methods
In a retrospective study we analysed the d ata o f 100 consecutive women who were adm itted for term ination o f pregnancy on the basis o f structural and chrom o- somal fetal anom alies at the University H ospital, R o t terdam . In the period from September 1989 to January 1993, three different regimens were used in a m ore or less chronological order: (1) Repeated intram uscular in jections o f sulprostone, at the rate o f one injection o f 500 n g every 4 h for 24 h, followed by a sulprostone-free interval o f 24 h. This regimen was repeated until deliv ery; (2) C ontinuous intravenous infusion o f sulprostone at the rate o f 2 /tg/min for 24 h, followed by a sulprostone-free interval o f 24 h. This regimen was re peated until delivery; (3) C ontinuous intravenous infu sion o f sulprostone identical to Regimen 2 was initiated 12-16 h after a single intracervical dose o f 0.5 mg dinoprostone, if the patient had n o t delivered within that time.
We studied the interval between initiation o f sulpros tone therapy and the expulsion o f the fetus for the three regimen groups. We perform ed tw o analyses: one based on a division according to parity and one based on a di vision into prim igravidae vs. m ultigravidae. We report median values and ranges, and we used the W ilcoxon's rank sum test and the C hi-square test for statistical anal ysis. A P-value o f < 0.05 was taken as the level o f signif icance.
Results
A total o f 100 women were adm itted to the University Hospital, R otterdam , for term ination o f m idgestation pregnancy after diagnosis o f a congenital anom aly o f the fetus. From September 1989 until July 1991, Regimen 1 or 2 were used in 56 o f these patients, 19 nulliparae and 37 parae; from July 1991 until January 1993 Regimen 3 was used in 44 patients, 22 nulliparae and 22 parae. All patients who underw ent term ination delivered vaginally w ithout m ajor side effects o f the m edication, o r any other m ajor com plication. Table 1 shows the differences in gestational age and interval between the initiation o f sulprostone treatm ent and delivery, according to parity and regimen. There were no significant differences in gestational age be tween subgroups. The induction-to-delivery interval was lower in parous than in nulliparous women (by approx imately 8.5 h). The difference in interval between parous and nulliparous women was significant in the women treated with sulprostone only (approxim ately 10 h), but not in those women pretreated with dinoprostone (ap proximately 4.5 h). In the dinoprostone pretreated group two women (one nullipara and one para) deliv ered before sulprostone induction was initiated. A lthough the women who were pretreated with dinoprostone tended to have shorter intervals than the women who were treated with sulprostone only (by ap proximately 8 h for nulliparae and 2 h for parae), these differences were not significant, both com pared to sul prostone i.v. only and to sulprostone i.v. and i.m. com bined, due to m arked variation between individuals.
O f the total group o f 41 nulliparae, 31 were prim igravida at the time o f pregnancy term ination and 10 were in their second o r subsequent pregnancy. O f these women, one had a spontaneous abortion plus dilatation and curettage, four women had an elective abortion through vacuum curettage, one w om an had a previous m idgestation term ination with sulprostone; the other women had a history o f a com bination o f these. Table 2 shows the differences in gestational age and induction-to-delivery interval, according to gravidity and regimen. There were no significant differences in gestational age between subgroups. The induction-todelivery interval was significantly shorter in m ulti gravidae than in prim igravidae by approxim ately 7 h. The difference in interval between m ultigravidae and primigravidae was significant in the women treated with sulprostone only (approxim ately 10 h), but n o t in those M edian value w ith ranges in brackets.
* P < 0.05 com pared w ith sulprostone only. * * P < 0.05 com pared w ith prim igravidae.
women pretreated with dinoprostone (approxim ately 1 h). In the dinoprostone pretreated group, tw o women (one prim igravida and one m ultigravida) delivered before sulprostone induction was initiated. In prim i gravidae who received pretreatm ent w ith dinoprostone, the induction-to-delivery interval was significantly reduced (by approxim ately 10.5 h) as com pared to women who received sulprostone only, both com pared to sulprostone i.v. only and to sulprostone i.v. and i.m. combined. In m ultigravidae, pretreatm ent w ith dino prostone did n o t result in a significant reduction o f the induction-to-delivery interval. Seventy-eight women, 28 o f 41 nulliparae (68%) and 50 o f 59 parae (85%), 21 o f 31 prim igravidae (68%) and 57 o f 69 (83%) m ultigravidae, delivered within 24 h after initiation o f sulprostone treatm ent. A significantly higher percentage o f nulliparous women delivered < 24 h after initiation o f sulprostone treatm ent following dinoprostone prim ing (18/22, 82%) than w ithout prim ing (10/19, 53%). Similarly, a significantly higher percen tage o f prim igravidae delivered < 24 h after initiation of sulprostone prim ing (13/15, 87%) than w ithout prim ing (8/16, 50%). D inoprostone prim ing had no significant effect on the chance to deliver < 24 h after the initiation o f sulprostone treatm ent in parae and multigravidae.
Discussion
If it is necessary to term inate a pregnancy in m idgesta tion, it is desirable th at the technique o f term ination is optim ally effective, w ith m inim al side effects. Therefore, the duration o f hospital adm ission and the interval from initiation o f treatm ent to delivery should be as short as possible. In addition, a recent study has shown th at an infusion rate o f sulprostone h alf th a t o f which was used in the present study is also effective [1] , A lthough the in tram uscular route o f sulprostone is no longer used be cause o f the risk o f overdosage, our study shows that intram uscularly and intraveneously adm inistered sul prostone are equally effective.
In term pregnancies, ripening o f the cervix with local ly applied prostaglandin E2 facilitates induction o f la bour and reduces the induction-to-delivery interval [2] , It is not well know n w hether this also applies to m idterm pregnancy. Several investigators have attem pted to im prove upon the technique o f m idgestation term ination with the use o f prostaglandins, and report a favorable effect o f pretreatm ent either through vaginal application o f prostaglandin E2 tablets [4] or cervical application o f sulprostone gel, prostaglandin E 2 o r F 2" gel [5, 6] . How ever, these studies all lack a control group, which limits their im portance.
We found th at the induction-to-delivery interval after sulprostone in m idgestation is m uch shorter in m ulti gravidae and parae com pared to prim igravidae and nulliparae. A pparently, the cervix dilates m ore easily after it has been previously dilated. Given the already short induction-to-delivery interval in m ultigravidae and parae it may n o t be surprising th a t the interval is not significantly shortened any further by pretreatm ent o f the cervix with a locally applied, but weaker, pro staglandin analogue.
O ur observation th at pretreatm ent with dinoprostone does significantly reduce the induction-to-delivery inter val in prim igravidae but n o t in nulliparae suggests th at it makes little difference as to how the cervix has previously been artificially dilated. Because all o f the 10 multigravidae nulliparae had experienced an artificial type o f dilatation, it is uncertain to w hat extent a pre vious spontaneous abortion alone, w ithout dilatation, might affect the response to dinoprostone pretreatm ent in a subsequent pregnancy.
A lthough only a prospective, placebo-controlled, ran domized trial can answer definitively the question to what extent cervical prim ing with dinoprostone shortens the induction-to-delivery interval in m idpregnancy ter m ination with sulprostone, o u r retrospective study strongly suggests th at pretreatm ent w ith dinoprostone is indeed effective in prim igravidae. W hen dinoprostone on this indication is adm inistered on an o utpatient basis, in primigravidae the duration o f hospitalization for sul prostone term ination in m idpregnancy can be reduced.
